NEWS
View news from our Featured Companies.
Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz® for Actinic Keratoses on Trunk and Extremities
Phase 1 maximal-use pharmacokinetics (PK) study completed in support of planned U.S. label expansionData to complement previously announced positive Phase 3 efficacy results on extremities, neck and trunkSupplemental NDA submission for extremities, neck and trunk...
Taseko to Release Fourth Quarter and Year End 2025 Results
VANCOUVER, British Columbia, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (the "Company") will release its fourth quarter and year end 2025 financial results after market close on Wednesday, February 18, 2026. The...
Precision Optics Schedules Second Quarter of Fiscal Year 2026 Conference Call for February 17, 2026
GARDNER, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has...
Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in Superficial Basal Cell Carcinoma
Prescription Drug User Fee Act (PDUFA) target action date set for September 28, 2026If approved, Ameluz® would be the first and only PDT photosensitizer indicated for the treatment of superficial Basal Cell Carcinoma (sBCC) in the USBCC is the most common skin...
Comstock Inc. Featured on Water Tower Research Small-Cap Spotlight Podcast
VIRGINIA CITY, Nev., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" or the "Company") and its subsidiary, Comstock Metals LLC ("Comstock Metals"), a leader in the responsible recycling of end-of-life solar panels and the only certified,...
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
The Company is in Advanced Stages of Commercial U.S. Partnership Discussions for D-PLEX Positive FDA Pre-NDA Feedback Supports Rolling NDA Review; Submission Expected to Begin by the End of the First Quarter of 2026 Conference Call Scheduled for Today at 8:30 AM ET...
SenesTech Strengthens Direct-to-Consumer Commercial Strategy by Directly Managing Amazon Sales of Evolve™ Rat and Evolve™ Mouse
Transition from Third-Party to Internal Management Expected to Increase Revenue and Enhance Margin on E-Commerce Channel Moving Forward While Building on Early Success PHOENIX, Feb. 10, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES) today announced that it will...
IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share
Reports record revenue of $22.7 million for the fourth quarter of 2025, an increase of $3.3 million, or 17%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.50 and non-GAAP diluted EPS of $0.54 for the fourth quarter of 2025, which are...
Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint
Study findings met its primary endpoint and showed highly statistically significant superiority for Ameluz® vs. vehicle gel (p<0.0003)Actinic keratosis (AK) is the most common skin condition diagnosed by US dermatologists1If left untreated, AK may progress to...
Comstock Metals Awarded Tax Abatement From the Nevada Governor’s Office of Economic Development
VIRGINIA CITY, Nevada, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company") and its subsidiary, Comstock Metals LLC ("Comstock Metals"), a leader in the responsible recycling of end-of-life solar panels and the only certified,...
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026
ORLANDO, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 fourth quarter and full year financial results before the market opens on Tuesday, February 10, 2026. Iradimed management will...
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
Total net revenue of $15.2 millionAdjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments$30.0 million cash balance at December 31, 2025Company launched EXXUA™ (gepirone) extended-release tablets ("EXXUA") in December 2025 as the centerpiece...
SenesTech’s Evolve® Approved in New Zealand
Supporting New Zealand's Predator Free 2050 Initiative Initial Stocking Order Fulfilled PHOENIX, Feb. 2, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce that...
Orion Digital Corp. Announces Monetization of Remaining WonderFi Investment, Strengthening Balance Sheet
VANCOUVER, British Columbia - Orion Digital Corp. (NASDAQ: ORIO; TSX: ORIO) ("Orion Digital" or the "Company"), a founder-led digital finance platform operating primarily across wealth, payments, and digital assets, today announced that it exited its remaining equity...
Comstock to Host Business Update Webinar
VIRGINIA CITY, Nev., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company") is pleased to announce that the Company's Executive Chairman & CEO, Corrado De Gasperis, and CFO, Judd Merrill will be providing an overview of the...
Comstock Inc. Prices $50 Million Upsized and Oversubscribed Public Offering of Common Stock
VIRGINIA CITY, Nev., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company"), today announced that it has priced its previously announced underwritten public offering of 18,181,819 shares of its common stock. All of the shares of...
SenesTech Announces CEO Transition Plan
Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions...
Comstock Inc. Announces Proposed Public Offering of Common Stock
VIRGINIA CITY, Nev., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company"), today announced that it has commenced an underwritten public offering for the sale of its common stock. In connection with the offering, Comstock expects...
PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026
PETACH TIKVA, Israel, Jan. 28, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter 2025 financial results and...
Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026
DENVER, CO / ACCESS Newswire / January 27, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients,...
Hotel101 Global Holdings Corp. Announces Proposed Offering of Convertible Preferred Shares to raise up to USD 300 Million
This proposed capital raise is expected to fuel the prop-tech, asset-light HBNB business model towards its next growth stage of worldwide expansionSINGAPORE, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Hotel101 Global Holdings Corp. (NASDAQ: HBNB) ("HBNB," "Hotel101 Global" or...
ARIANNE PHOSPHATE SUCCESSFULLY PRODUCES A HIGHER GRADE/LOWER CONTAMINANT PHOSPHATE CONCENTRATE
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQB (USA) -Concentrate ideally suited for the specialty & LFP markets SAGUENAY, QC, Jan. 22, 2026 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQB: DRRSF) (FRANKFURT: JE9N), a...
Comstock Sells NSR Royalty To Mackay Precious Metals Inc.
VIRGINIA CITY, Nev., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company") today announced it has received the final $1 million from Mackay Precious Metals Inc. ("Mackay"), completing an agreement to sell its residual 1.5% net...
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients,...
Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
EXXUA addresses frequent causes of treatment discontinuation with first-line SSRIs and SNRIsNow commercially available through retail pharmacies and participating Aytu RxConnect® pharmacies to support patient access DENVER, COLORADO / ACCESS Newswire / January...